The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Active, not recruiting · NCT01706939 · Registry updated 2026-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Active, not recruiting | Phase 3 | 2026-04-09 | NCT01706939 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Arizona State University | 77 |
| Biodesign Institute | 1 |
| Icahn School of Medicine at Mount Sinai | 256 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |